The alternatives
FuturHealth scores 58/100 (grade C, ranked #389) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to FuturHealth's 58, and our FuturHealth vs CoreAge Rx ruling sets the two out factor by factor.
Men's health telehealth brand offering GLP-1 weight loss treatments.
Dollar Dad Club matches FuturHealth at 58/100; the full Dollar Dad Club review has the pricing conditions and the caveats in detail.
Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.
LillyDirect Foundayo matches FuturHealth at 58/100; our LillyDirect Foundayo ruling in full has the pricing conditions and the caveats in detail.
Actin offers compounded semaglutide with B12 for weight loss.
Actin matches FuturHealth at 58/100; our full write-up on Actin has the pricing conditions and the caveats in detail.
Medi-Weightloss is an established physician-supervised weight-loss brand with 130-plus locations nationwide plus telehealth.
Medi-Weightloss matches FuturHealth at 58/100; the full Medi-Weightloss review has the pricing conditions and the caveats in detail.
NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
NuuVim scores 59/100 to FuturHealth's 58; the full NuuVim review has the pricing conditions and the caveats in detail.
Push Health is a large US telehealth platform that routes brand-name GLP-1 prescriptions (Ozempic, Zepbound, Mounjaro) through a 55,000+ pharmacy network.
Push Health matches FuturHealth at 58/100; our Push Health ruling in full has the pricing conditions and the caveats in detail.
See the complete rankings or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.